Insights into structure-reactivity-activity relationships for covalent inhibitors from profiling the EGFR activity of poziotinib analogues
Waring, M.To be published.
Experimental Data Snapshot
Starting Model: experimental
View more details
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Epidermal growth factor receptor | 329 | Homo sapiens | Mutation(s): 0  Gene Names: EGFR, ERBB, ERBB1, HER1 EC: 2.7.10.1 | ![]() | |
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for P00533 (Homo sapiens) Explore P00533  Go to UniProtKB:  P00533 | |||||
PHAROS:  P00533 GTEx:  ENSG00000146648  | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | P00533 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
A1IHC (Subject of Investigation/LOI) Query on A1IHC | B [auth A] | 1-[(3~{S})-3-[4-[(3-chloranyl-4-fluoranyl-phenyl)amino]-7-methoxy-quinazolin-6-yl]oxypyrrolidin-1-yl]propan-1-one C22 H22 Cl F N4 O3 GBUJQSIKHBSPDW-AWEZNQCLSA-N |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 145.823 | α = 90 |
b = 145.823 | β = 90 |
c = 145.823 | γ = 90 |
Software Name | Purpose |
---|---|
REFMAC | refinement |
xia2 | data reduction |
pointless | data scaling |
PHASER | phasing |
Funding Organization | Location | Grant Number |
---|---|---|
Cancer Research UK | United Kingdom | C2115/A21421 |
Engineering and Physical Sciences Research Council | United Kingdom | EP/R51309X/1 |
Cancer Research UK | United Kingdom | DRCDDRPGMApr2020100002 |